| A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients (NCT03677596) | Pfizer | 2019-07-01 |
| Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis (NCT03970733) | Pfizer | 2019-07-01 |
| A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis (NCT03895372) | Pfizer | 2019-06-27 |
| Trial for Treatment Refractory Trigeminal Neuralgia (NCT03941834) | Pfizer | 2019-06-25 |
| Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis (NCT03954158) | Pfizer | 2019-06-15 |
| A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis (NCT03963401) | Pfizer | 2019-06-13 |
| Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants (NCT03978143) | Pfizer | 2019-06-12 |
| An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer (NCT03915951) | Pfizer | 2019-06-04 |
| Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in France (NCT03621072) | Pfizer | 2019-06-03 |
| Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors (NCT03709680) | Pfizer | 2019-05-24 |
| A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants (NCT03937258) | Pfizer | 2019-05-21 |
| A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients (NCT04047121) | Pfizer | 2019-05-20 |
| Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings. (NCT05155566) | Pfizer | 2019-05-15 |
| Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis (NCT03903822) | Pfizer | 2019-05-13 |
| Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland (NCT05363488) | Pfizer | 2019-05-01 |
| An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis (NCT03911869) | Pfizer | 2019-04-30 |
| A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China (NCT03909971) | Pfizer | 2019-04-28 |
| Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600. (NCT03929510) | Pfizer | 2019-04-23 |
| THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS (NCT03916406) | Pfizer | 2019-04-18 |
| A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) (NCT03845517) | Pfizer | 2019-04-18 |
| PF-06651600 Taste Study. (NCT03916393) | Pfizer | 2019-04-15 |
| Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR) (NCT04018001) | Pfizer | 2019-04-12 |
| Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis (NCT03850483) | Pfizer | 2019-04-08 |
| Evaluate Severe Hepatic Impairment on Dacomitinib PK (NCT03865446) | Pfizer | 2019-04-05 |
| Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study (NCT03918629) | Pfizer | 2019-04-01 |
| Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets (NCT03803371) | Pfizer | 2019-03-26 |
| Acute Treatment Trial in Adult Subjects With Migraines (NCT03872453) | Pfizer | 2019-03-25 |
| Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants (NCT03916250) | Pfizer | 2019-03-23 |
| Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis) (NCT03885037) | Pfizer | 2019-03-20 |
| Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis) (NCT03884439) | Pfizer | 2019-03-18 |
| A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors (NCT03854227) | Pfizer | 2019-03-14 |
| OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS (NCT03871439) | Pfizer | 2019-03-13 |
| UK Ibrance Patient Program (IPP) Study (NCT03921866) | Pfizer | 2019-03-01 |
| Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single-Dose of PF-06651600 in Healthy Participants (NCT03821493) | Pfizer | 2019-02-21 |
| JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis (NCT03796676) | Pfizer | 2019-02-18 |
| Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults (NCT03828617) | Pfizer | 2019-02-14 |
| Treatment Resistance Following Anti-cancer Therapies (NCT04436120) | Pfizer | 2019-02-13 |
| Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination (NCT03835975) | Pfizer | 2019-02-12 |
| A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS (NCT03827668) | Pfizer | 2019-02-07 |
| Diflucan Bioequivalence Study For Transferring The Manufacture (NCT03821480) | Pfizer | 2019-01-28 |
| Long Term Safety Observation of Crizotinib in Chinese NSCLC Population (NCT03672643) | Pfizer | 2019-01-28 |
| Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy (NCT04176354) | Pfizer | 2019-01-25 |
| Safety and Efficacy of Lorbrena (NCT03844464) | Pfizer | 2019-01-21 |
| A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males (NCT03792477) | Pfizer | 2019-01-19 |
| Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants (NCT03765073) | Pfizer | 2019-01-14 |
| Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants (NCT03796182) | Pfizer | 2019-01-10 |
| Clinical Study to Evaluate Blood Concentrations of PF-06700841 After Oral Dose as Different Formulations (NCT03765554) | Pfizer | 2019-01-07 |
| A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. (NCT03776175) | Pfizer | 2019-01-04 |
| RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S. (NCT04460898) | Pfizer | 2019-01-04 |
| IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis (NCT03981900) | Pfizer | 2019-01-04 |
| Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics (NCT03964649) | Pfizer | 2019-01-01 |
| Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers (NCT03722238) | Pfizer | 2018-12-27 |
| Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study. (NCT03769194) | Pfizer | 2018-12-17 |
| Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India (NCT03777865) | Pfizer | 2018-12-14 |
| Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults (NCT03760146) | Pfizer | 2018-12-12 |
| Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects (NCT03770039) | Pfizer | 2018-12-10 |
| ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ (NCT03762928) | Pfizer | 2018-12-07 |
| PF-06651600 for the Treatment of Alopecia Areata (NCT03732807) | Pfizer | 2018-12-03 |
| PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release Formulation (NCT04403776) | Pfizer | 2018-12-03 |
| Real-World Observational Study Of Zavicefta to Characterize Use Patterns (NCT03923426) | Pfizer | 2018-11-27 |
| Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC (NCT03674827) | Pfizer | 2018-11-27 |
| A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects (NCT03715829) | Pfizer | 2018-11-26 |
| Palatability (Taste) of Oral Formulations of Bosutinib (NCT03747679) | Pfizer | 2018-11-22 |
| Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants (NCT03742336) | Pfizer | 2018-11-21 |
| Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements (NCT03760042) | Pfizer | 2018-11-14 |
| Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults (NCT03732638) | Pfizer | 2018-11-14 |
| A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants (NCT03782662) | Pfizer | 2018-11-07 |
| A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib (NCT03627754) | Pfizer | 2018-11-05 |
| A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. (NCT03580005) | Pfizer | 2018-10-31 |
| Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy (NCT03720470) | Pfizer | 2018-10-29 |
| A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) (NCT03448692) | Pfizer | 2018-10-15 |
| A Renal Impairment Study for PF-04965842 (NCT03660241) | Pfizer | 2018-10-05 |
| PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors (NCT03685591) | Pfizer | 2018-10-04 |
| A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day (NCT04267380) | Pfizer | 2018-09-30 |
| Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826) (NCT03662191) | Pfizer | 2018-09-28 |
| A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects (NCT03662516) | Pfizer | 2018-09-26 |
| Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD. (NCT03546400) | Pfizer | 2018-09-25 |
| A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC) (NCT03608241) | Pfizer | 2018-09-21 |
| A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD (NCT03536390) | Pfizer | 2018-09-19 |
| Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842. (NCT03637790) | Pfizer | 2018-09-13 |
| Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842. (NCT03634345) | Pfizer | 2018-09-12 |
| A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers (NCT03656952) | Pfizer | 2018-09-05 |
| Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib (NCT04076787) | Pfizer | 2018-09-01 |
| Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age (NCT03642847) | Pfizer | 2018-08-29 |
| Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (NCT03499353) | Pfizer | 2018-08-27 |
| A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects (NCT03612557) | Pfizer | 2018-08-20 |
| Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics (NCT03593707) | Pfizer | 2018-08-17 |
| A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors (NCT03637491) | Pfizer | 2018-08-15 |
| Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis (NCT03486457) | Pfizer | 2018-08-10 |
| A Safety Study For Prevenar 13 Among Chinese Children (NCT03656939) | Pfizer | 2018-08-01 |
| Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age (NCT03579459) | Pfizer | 2018-07-31 |
| Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects (NCT03599063) | Pfizer | 2018-07-30 |
| A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) (NCT03587116) | Pfizer | 2018-07-26 |
| Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) (NCT03642132) | Pfizer | 2018-07-19 |
| A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years. (NCT03571607) | Pfizer | 2018-07-12 |
| Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology (NCT03842163) | Pfizer | 2018-07-09 |
| A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers (NCT03647670) | Pfizer | 2018-07-03 |
| BESPONSA Injection 1 mg Special Investigation (NCT05923112) | Pfizer | 2018-07-02 |
| Rheumatoid Arthritis Satisfaction Outcome Research (NCT03703817) | Pfizer | 2018-07-02 |
| A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin (NCT03386279) | Pfizer | 2018-07-02 |